To investigate this, we modified the sialylation pathway of GSLs in two murine CRC models (MC38 and CT26 cells) by knocking out the ST3Gal5 gene using CRISPR/Cas9 genome engineering. The gene discussed is ST3GAL5; the disease is colorectal carcinoma.